Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Ethiopia

Ethiopia

The projected revenue for the Other Vaccines market in Ethiopia is expected to reach US$11.14m in 2024.
It is anticipated that the revenue will show an annual growth rate of 11.70% from 2024 to 2029, resulting in a market volume of US$19.37m by 2029.
In comparison to other countries worldwide, United States is expected to generate the highest revenue in this market, with US$24,730.00m in 2024.
Ethiopia's demand for other vaccines is increasing due to a growing awareness of the importance of immunization in preventing diseases.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Ethiopian market for Other Vaccines has been steadily developing in recent years.

Customer preferences: Ethiopia has a population of over 100 million people, with a high birth rate and a young demographic. This has led to an increasing demand for vaccines, including Other Vaccines, which are used to prevent diseases such as meningococcal disease, pneumococcal disease, and rotavirus.

Trends in the market: The Ethiopian government has been investing in the healthcare sector, including the vaccination program, which has contributed to the growth of the Other Vaccines market. There has also been an increase in public awareness about the importance of vaccination, leading to more people seeking out vaccines for themselves and their families. In addition, the rise of private healthcare providers in urban areas has created a new market for Other Vaccines.

Local special circumstances: Ethiopia has a high burden of infectious diseases, including vaccine-preventable diseases. The government has therefore prioritized the vaccination program as part of its efforts to improve public health. However, there are challenges to vaccine delivery in Ethiopia, including limited infrastructure and resources in rural areas, as well as vaccine hesitancy among some communities.

Underlying macroeconomic factors: Ethiopia is one of the fastest-growing economies in Africa, with a young and growing population. This has created a favorable environment for the healthcare sector, including the Other Vaccines market. However, there are also challenges to the economy, including high levels of poverty and limited resources, which can impact access to healthcare services and vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.